Independent · evidence-anchored·Reviewed by the GLPHelper Medical Team
EN·ES
glp·helper
Find a Provider →
glphelper.com/zepbound/kansas/overland-park
Dual GIP / GLP-1 receptor agonistFDA-approved November 2023Rx · Subcutaneous injection · Once weekly

Zepbound® providers &
prescriptions in Overland Park, KS

Verified Zepbound providers in Overland Park, KS. Checked against the NPI registry, sorted by waitlist, not by who pays us.[7]

average Zepbound weight loss →trial-anchored estimate
city providers
32
as of today
median wait
8d
first visit
telehealth
71%
of providers
cash range
$25 to $1,150
monthly
§ 02Provider directory: Kansas
32 of 32 shown

Find a Zepbound provider in Kansas.

Every entry is checked against the NPI registry and the Kansas medical board. Listings are ordered by current waitlist. The provider who can see you fastest appears first. We do not accept payment for placement.

Filter →
Type
Provider
City
Waitlist
Insurance
Browse by Kansas city · /zepbound/kansas/{city}
Topeka
34 →
Wichita
36 →
§ 03Getting Zepbound in Overland Park
32 providers · Overland Park, KS

How to get Zepbound in Overland Park.

32 GLP-1 prescribers and 7 local resource types are on record for Overland Park, plus 2 nearby towns in the directory.

Prescribers in Overland Park
32 prescribers
32 GLP-1 prescribers in Overland Park, most listed as Family Medicine (14), Internal Medicine, Endocrinology, Diabetes & Metabolism (10) and Internal Medicine (8). Any Kansas-licensed physician, nurse practitioner, or PA can prescribe Zepbound, over video or in person. The nearest towns on record are Topeka (34 providers) and Wichita (36 providers).
Around the prescription in Overland Park
7 listed nearby
6 dietitians, 1 nutritionists, 6 gyms, 6 fitness clubs, 6 trainers, 6 physiotherapists and 6 places to move are on record near Overland Park.
Medicaid (weight loss)
Limited
As of April 2026, Kansas Medicaid covers GLP-1s for weight loss only in limited cases (limited to a severe-obesity pathway). Diabetes coverage is broader. Employer and private plans vary by plan.

Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Kansas’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.

§ 04Medication factsheet
cited · last review 2026.05.19

An injectable medication for chronic weight management in adults. Same molecule as Mounjaro.

Zepbound is the brand name Eli Lilly uses for tirzepatide approved for chronic weight management. It is a once-weekly subcutaneous injection and the first approved dual GIP/GLP-1 receptor agonist. The identical molecule, marketed as Mounjaro, is the FDA-approved formulation for type 2 diabetes.[2][3]

In SURMOUNT-1, adults with obesity (without diabetes) lost a mean of 20.9% of body weight on the 15 mg dose at 72 weeks, versus 3.1% with placebo. That is among the largest average weight reductions reported for an anti-obesity medication. Zepbound is approved as an adjunct to a reduced-calorie diet and increased physical activity.[1]

At a glanceMultiple (per dose)
Generic name
tirzepatide
Drug class
Dual GIP / GLP-1 receptor agonist
Manufacturer
Eli Lilly
FDA approved
November 2023
Approved use
Chronic weight management (adults with obesity, or overweight with a weight-related condition)
Off-label use
Type 2 diabetes (Mounjaro is the FDA-approved tirzepatide for diabetes)
Administration
Subcutaneous injection · Once weekly
Available doses
2.5 mg · 5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg
Half-life
≈ 5 days
Pregnancy
Discontinue ≥ 2 months before a planned pregnancy; may reduce oral contraceptive efficacy

Community health · CDC

Weight & metabolic health in Kansas

Diagnosed diabetes reaches 10.5% of adults in Kansas.

of Kansas adults have obesity
37.6%
diagnosed diabetes
10.5%

Age-adjusted estimates for Kansas, community figures, not individual risk. CDC BRFSS 2024.

Estimate your weight losswhy facial fat loss happens
§ 05Support around Zepbound in Overland Park
6 fitness clubs

The prescription is one part. Here is the rest, in Overland Park.

Trials of tirzepatide paired the drug with diet counseling and regular activity. Every name below is a real listing near Overland Park, KS, ordered as the registry lists them, never by who pays us.

Fitness clubs and recreation centers

Fitness clubs and recreation centers run classes and pools, an easier start than a weight room.

Lenexa Rec Center
REC CENTER
4.6 on Google · 748 reviews
17201 W 87th St Pkwy
Website
Life Time
FITNESS
3.9 on Google · 493 reviews
6800 138th St
Website
Blue Valley Recreation Center at Hilltop
REC CENTER
4.6 on Google · 439 reviews
7720 W 143rd St
Website
Blue Valley Recreation Activity Center
REC CENTER
4.6 on Google · 255 reviews
6545 W 151st St
Website
TITLE Boxing Club State Line
BOXING
4.8 on Google · 205 reviews
8029 State Line Rd
Website
Ace Pickleball Club
CLUB
4.9 on Google · 183 reviews
1445 S Mahaffie Cir
Website

Nutritionists

A nutritionist helps you get enough protein and fiber while the medication cuts your appetite. Call to ask what they cover.

Renee Hinz, MS, RD, LS
NUTRITIONIST
Nutritionist
10560 Barkley St
Call 913-383-3464NPI 1912229055
§ 06Clinical evidence
STEP 1 to 4 + SELECT (N = 17,604)

What the trials actually showed.

We summarize the SURMOUNT weight-management program. Figures are means at the 72-week primary endpoint, by dose.

SURMOUNT-1 randomized 2,539 adults with obesity (without diabetes) across 72 weeks. Mean weight change was −15.0% (5 mg), −19.5% (10 mg), and −20.9% (15 mg) versus −3.1% with placebo. A majority of patients on the higher doses lost ≥20% of body weight.[2]
STEP / SELECT endpoint table2.4 mg / 68 wk
Mean weight change (15 mg)
−20.9%
SURMOUNT-1, 72 wk vs −3.1% placebo[2]
Mean weight change (10 mg)
−19.5%
SURMOUNT-1, 72 wk[2]
Mean weight change (5 mg)
−15.0%
SURMOUNT-1, 72 wk[2]
Effect size varies with baseline characteristics and adherence. Individual response may differ materially.
average Zepbound weight loss →mapped to your starting weight
§ 07Safety & adverse events
from FDA label, sect. 6.1

Most side effects are gastrointestinal and resolve within weeks.

The most common adverse events in STEP trials were nausea (44%), diarrhea (30%), and vomiting (24%), more frequent at the 2.4 mg dose than at Ozempic doses, but typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]

Boxed warning. Boxed warning: risk of thyroid C-cell tumors. Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN-2).
Effect
Frequency
Severity
Note
Nausea
12 to 24%
mild
Dose-dependent; usually eases after titration
Diarrhea
12 to 19%
mild
More frequent during dose escalation
Vomiting
5 to 13%
mild
Reduced by slower titration
Constipation
6 to 17%
mild
Decreased appetite
5 to 11%
mild
Expected pharmacologic effect
Pancreatitis
<0.3%
serious
Discontinue if acute pancreatitis is suspected
Gallbladder disease
~1 to 2%
serious
Cholelithiasis risk rises with rapid weight loss
Thyroid C-cell tumors
rodent data
boxed warning
Contraindicated with MTC or MEN-2 history
§ 08Cost & coverage, published, not gated
USD · monthly

Most directories hide the price. We don't.

Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.

Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.

Zepbound cash price (no insurance)
$1,000 to $1,300
per month
Brand-name retail; Lilly self-pay vials lower for some doses[6]
Commercial insurance (weight)
Often denied
On-label for obesity but frequently requires prior authorization
Medicare Part D
Not covered
Weight-loss indication not covered by law[5]
Manufacturer savings card
as low as $25
per month
Commercial insurance with coverage only; eligibility limits apply
Updated weekly · last fetch 2026-05-18 04:00 UTCCost methodology →
Find Zepbound providers in Kansas

NPI-verified Zepbound (tirzepatide) prescribers and clinics, ordered by availability, never by who pays us.

Weight loss doctors in Kansas
Board-certified prescribers verified against the NPI registry.
Weight loss clinics in Kansas
Clinics running GLP-1 programs, telehealth & in-person.
Zepbound in other states

Find NPI-verified Zepbound (tirzepatide) doctors, clinics, and pharmacies in the states we cover, ordered by availability, never by who pays us.

Zepbound in Alabama→Zepbound in Alaska→Zepbound in Arizona→Zepbound in Arkansas→Zepbound in California→Zepbound in Colorado→Zepbound in Connecticut→Zepbound in Delaware→Zepbound in Florida→Zepbound in Georgia→Zepbound in Hawaii→Zepbound in Idaho→Zepbound in Illinois→Zepbound in Indiana→Zepbound in Iowa→Zepbound in Kansas→Zepbound in Kentucky→Zepbound in Louisiana→Zepbound in Maine→Zepbound in Maryland→Zepbound in Massachusetts→Zepbound in Michigan→Zepbound in Minnesota→Zepbound in Mississippi→Zepbound in Missouri→Zepbound in Montana→Zepbound in Nebraska→Zepbound in Nevada→Zepbound in New Hampshire→Zepbound in New Jersey→Zepbound in New Mexico→Zepbound in New York→Zepbound in North Carolina→Zepbound in North Dakota→Zepbound in Ohio→Zepbound in Oklahoma→Zepbound in Oregon→Zepbound in Pennsylvania→Zepbound in Rhode Island→Zepbound in South Carolina→Zepbound in South Dakota→Zepbound in Tennessee→Zepbound in Texas→Zepbound in Utah→Zepbound in Vermont→Zepbound in Virginia→Zepbound in Washington→Zepbound in West Virginia→Zepbound in Wisconsin→Zepbound in Wyoming→
Related GLP-1 research
when GLP-1 weight loss stalls
The plateau playbook: dose, habits, and what the trials say.
how tirzepatide titration works
Starting dose, step-ups, and the 2.5-to-15 mg ladder.
§ 09Frequently asked: Zepbound in Kansas

The questions people ask before they book.

Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.

Zepbound and Mounjaro are both tirzepatide, made by Eli Lilly, but they carry different FDA-approved indications. Zepbound is approved for chronic weight management; Mounjaro is approved for type 2 diabetes. Insurers treat them as separate products, and weight-loss coverage is far more restricted than diabetes coverage.[1]